1. Home
  2. OPK vs WVE Comparison

OPK vs WVE Comparison

Compare OPK & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

N/A

Current Price

$1.36

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$5.40

Market Cap

994.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPK
WVE
Founded
2006
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
994.1M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
OPK
WVE
Price
$1.36
$5.40
Analyst Decision
Hold
Strong Buy
Analyst Count
3
16
Target Price
$1.60
$29.81
AVG Volume (30 Days)
4.5M
2.9M
Earning Date
04-28-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$606,879,000.00
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$0.98
$5.01
52 Week High
$1.73
$21.73

Technical Indicators

Market Signals
Indicator
OPK
WVE
Relative Strength Index (RSI) 49.76 40.81
Support Level $1.25 N/A
Resistance Level $1.41 $6.39
Average True Range (ATR) 0.07 0.35
MACD 0.01 -0.05
Stochastic Oscillator 18.05 22.14

Price Performance

Historical Comparison
OPK
WVE

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: